Metropolis Healthcare Ltd (METROPOLIS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003129, "name": "Metropolis Healt", "stock_name": "Metropolis Healt", "full_name": "Metropolis Healthcare Ltd", "name_url": "stocks-analysis/metropolis-healt", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "563.35", "chg": 0.8, "chgp": "0.14%", "dir": 1, "prev_price": "562.55", "mcapval": "11,724.00 Cr", "mcap": "Small Cap", "scripcode": 542650, "symbol": "METROPOLIS", "ind_name": "Healthcare Services", "ind_code": 94, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE112L01020", "curr_date": "Aug 07, 03:30 PM", "curr_time": "05:09 AM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "1.42 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/metropolis-healt-1003129-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Metropolis Healthcare Falls 3.33%: Valuation Concerns Amid Mixed Weekly Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-falls-333-valuation-concerns-amid-mixed-weekly-moves-4143116", "imagepath": "", "date": "2026-08-08 12:07:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock opens strong at Rs.596.35 (+2.33%)</p>\n <p><strong>5 Aug:</strong> Q1 FY27 results announced; valuation shifts to very expensive</p>\n <p><strong>6 Aug:</strong> Continued price decline to Rs.562.55 (-2.76%)</p>\n <p><strong>7 Aug:</strong> Week closes at Rs.563.35 (+0.14%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.582.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.563.35</div><div class=\"stat-ch..." }, { "title": "Are Metropolis Healthcare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-metropolis-healthcare-ltd-latest-results-good-or-bad-4138491", "imagepath": "", "date": "2026-08-05 19:25:44", "description": "Metropolis Healthcare Ltd's latest financial results for Q1 FY27 highlight a robust operational performance, with net sales reaching ₹450.22 crores, marking a significant year-on-year growth of 16.62% and a sequential increase of 6.01%. This quarter represents the highest revenue recorded by the company, driven by strong demand for diagnostic services and successful network expansion initiatives.\n\nThe net profit for the quarter stood at ₹56.67 crores, reflecting a year-on-year growth of 25.77% and a quarter-on-quarter increase of 11.34%. This growth in net profit outpaced revenue growth, indicating improved operational leverage and effective cost management across various areas. The company's profit after tax margin improved to 12.63%, up from 12.00% in the previous quarter, showcasing its ability to enhance profitability despite rising employee costs.\n\nHowever, the operating margin, at 24.70%, saw a slight..." }, { "title": "Metropolis Healthcare Q1 FY27: Strong Growth Momentum Continues Amid Premium Valuations", "link": "https://www.marketsmojo.com/news/result-analysis/metropolis-healthcare-q1-fy27-strong-growth-momentum-continues-amid-premium-valuations-4138148", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MetropolisHealt_quaterlyResult_4138148.png", "date": "2026-08-05 09:52:40", "description": "Metropolis Healthcare Ltd., one of India's leading diagnostic services providers, reported robust quarterly results for Q1 FY27, with consolidated net profit surging 25.77% year-on-year to ₹56.67 crores, marking the company's strongest quarterly performance to date. The ₹11,991 crore market capitalisation company demonstrated sustained operational momentum, posting revenue growth of 16.62% YoY to ₹450.22 crores whilst maintaining healthy operating margins above 24%. Following the results announcement, the stock traded at ₹578.35, down 1.67% from the previous close, as investors digested the strong fundamentals against stretched valuation multiples." }, { "title": "Metropolis Healthcare Ltd Valuation Shifts to Very Expensive Amid Strong Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-ltd-valuation-shifts-to-very-expensive-amid-strong-returns-4136941", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MetropolisHealt_valuationdot_4136941.png", "date": "2026-08-05 08:03:27", "description": "Metropolis Healthcare Ltd, a prominent player in the healthcare services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This article analyses the implications of these changes in price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to assess the stock’s current price attractiveness." }, { "title": "Metropolis Healthcare Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/metropolis-healthcare-ltd-is-rated-hold-by-marketsmojo-4132416", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MetropolisHealt_mojoScore_4132416.png", "date": "2026-08-02 10:10:03", "description": "Metropolis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Broad-Based Technical Strength Lifts Metropolis Healthcare Ltd to 52-Week High of Rs 602.45", "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-ltd-hits-new-52-week-high-at-rs60245-4128644", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MetropolisHealt_priceRelatedfactors_4128644.png", "date": "2026-07-30 10:37:02", "description": "With a decisive break above Rs 600, Metropolis Healthcare Ltd has reached a new 52-week high of Rs 602.45 on 30 Jul 2026, marking a significant milestone in its price momentum. This surge comes amid a sustained rally that has seen the stock gain nearly 6% over the past five trading sessions, outperforming its sector peers and reflecting a strong alignment of technical indicators." }, { "title": "When is the next results date for Metropolis Healthcare Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-metropolis-healthcare-ltd-4127640", "imagepath": "", "date": "2026-07-29 23:17:21", "description": "The next results date for Metropolis Healthcare Ltd is scheduled for August 4, 2026...." }, { "title": "Metropolis Healthcare Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/metropolis-healthcare-ltd-is-rated-hold-4115197", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MetropolisHealt_mojoScore_4115197.png", "date": "2026-07-22 10:10:03", "description": "Metropolis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Metropolis Healthcare Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/metropolis-healthcare-ltd-is-rated-hold-4097051", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MetropolisHealt_mojoScore_4097051.png", "date": "2026-07-11 10:10:04", "description": "Metropolis Healthcare Ltd is rated Hold by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 July 2026, providing investors with the most recent insights into its performance and outlook." } ], "total": 322, "sid": "1003129", "stock_news_url": "https://www.marketsmojo.com/news/metropolis-healthcare-1003129" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "05-Aug-2026", "details": "Link of audio recording of the earnings conference call held on August 05 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "05-Aug-2026", "details": "Newspaper Publication", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "04-Aug-2026", "details": "Press Release", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Metropolis Healthcare Ltd has declared <strong>50%</strong> dividend, ex-date: 19 May 26", "dt": "2026-05-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Metropolis Healthcare Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 20 Mar 26", "dt": "2026-03-20", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Stock opens strong at Rs.596.35 (+2.33%)

5 Aug: Q1 FY27 results announced; valuation shifts to very expensive

6 Aug: Continued price decline to Rs.562.55 (-2.76%)

7 Aug: Week closes at Rs.563.35 (+0.14%)

Read full news article

Are Metropolis Healthcare Ltd latest results good or bad?

2026-08-05 19:25:44

Metropolis Healthcare Ltd's latest financial results for Q1 FY27 highlight a robust operational performance, with net sales reaching ₹450.22 crores, marking a significant year-on-year growth of 16.62% and a sequential increase of 6.01%. This quarter represents the highest revenue recorded by the company, driven by strong demand for diagnostic services and successful network expansion initiatives. The net profit for the quarter stood at ₹56.67 crores, reflecting a year-on-year growth of 25.77% and a quarter-on-quarter increase of 11.34%. This growth in net profit outpaced revenue growth, indicating improved operational leverage and effective cost management across various areas. The company's profit after tax margin improved to 12.63%, up from 12.00% in the previous quarter, showcasing its ability to enhance profitability despite rising employee costs. However, the operating margin, at 24.70%, saw a slight...

Read full news article

Metropolis Healthcare Q1 FY27: Strong Growth Momentum Continues Amid Premium Valuations

2026-08-05 09:52:40

Metropolis Healthcare Ltd., one of India's leading diagnostic services providers, reported robust quarterly results for Q1 FY27, with consolidated net profit surging 25.77% year-on-year to ₹56.67 crores, marking the company's strongest quarterly performance to date. The ₹11,991 crore market capitalisation company demonstrated sustained operational momentum, posting revenue growth of 16.62% YoY to ₹450.22 crores whilst maintaining healthy operating margins above 24%. Following the results announcement, the stock traded at ₹578.35, down 1.67% from the previous close, as investors digested the strong fundamentals against stretched valuation multiples.

Read full news article

Metropolis Healthcare Ltd Valuation Shifts to Very Expensive Amid Strong Returns

2026-08-05 08:03:27

Metropolis Healthcare Ltd, a prominent player in the healthcare services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This article analyses the implications of these changes in price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to assess the stock’s current price attractiveness.

Read full news article

Metropolis Healthcare Ltd is Rated Hold by MarketsMOJO

2026-08-02 10:10:03

Metropolis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Metropolis Healthcare Ltd to 52-Week High of Rs 602.45

2026-07-30 10:37:02

With a decisive break above Rs 600, Metropolis Healthcare Ltd has reached a new 52-week high of Rs 602.45 on 30 Jul 2026, marking a significant milestone in its price momentum. This surge comes amid a sustained rally that has seen the stock gain nearly 6% over the past five trading sessions, outperforming its sector peers and reflecting a strong alignment of technical indicators.

Read full news article

When is the next results date for Metropolis Healthcare Ltd?

2026-07-29 23:17:21

The next results date for Metropolis Healthcare Ltd is scheduled for August 4, 2026....

Read full news article

Metropolis Healthcare Ltd is Rated Hold

2026-07-22 10:10:03

Metropolis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Metropolis Healthcare Ltd is Rated Hold

2026-07-11 10:10:04

Metropolis Healthcare Ltd is rated Hold by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 July 2026, providing investors with the most recent insights into its performance and outlook.

Read full news article